Back to UBS Group AG UBS Group AG

SMMTSMMT
24 quarters

Position history for UBS Group AGUBS Group AG's holdings in SUMMIT THERAPEUTICS INC

UBS Group AG holds 5.2M shares of SMMT (SUMMIT THERAPEUTICS INC), worth $76.3M as of 2026-Q2. The position was increased (+42.2% shares). SMMT represents 0.0% of UBS Group AG's portfolio.

Current Value

$76.3M

Current Shares

5.2M

Total Value Change

+$75.8M

Total Shares Change

+5.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.2M
+42.2%
$76.3M0.0%$14.57
40
2026-Q1
Increased
3.7M
+322.7%
$69.8M0.0%$15.11
48
2025-Q4
Decreased
870,719
-31.9%
$15.2M0.0%$17.49
0
2025-Q3
Decreased
1.3M
-38.9%
$26.4M0.0%$21.16
0
2025-Q2
Increased
2.1M
+65.6%
$44.6M0.0%$20.60
43
2025-Q1
Increased
1.3M
+6.6%
$24.4M0.0%$20.32
31
2024-Q4
Increased
1.2M
+890.1%
$21.2M0.0%$17.89
46
2024-Q3
Decreased
119,819
-28.6%
$2.6M0.0%$20.89
0
2024-Q2
Decreased
167,867
-64.8%
$1.3M0.0%$7.80
0
2024-Q1
Increased
476,942
+215.3%
$2M0.0%$4.14
42
2023-Q4
Increased
151,268
+54.7%
$394,8090.0%$2.61
34
2023-Q3
Increased
97,786
+86.8%
$182,8600.0%$1.87
35
2023-Q2
Decreased
52,335
-67.8%
$131,3610.0%$2.51
0
2023-Q1
Increased
162,437
+6590.2%
$284,2650.0%$1.63
38
2022-Q4
Decreased
2,428
-95.1%
$10,3190.0%$4.25
0
2022-Q3
Decreased
49,245
-22.3%
$58,0000.0%$1.15
0
2022-Q2
Decreased
63,336
-22.9%
$63,0000.0%$0.97
0
2022-Q1
Decreased
82,194
-29.3%
$201,0000.0%$2.58
0
2021-Q4
Decreased
116,303
-6.5%
$313,0000.0%$2.55
0
2021-Q3
Decreased
124,341
-0.4%
$623,0000.0%$4.83
0
2021-Q2
Decreased
124,794
-0.9%
$931,0000.0%$7.43
0
2021-Q1
Decreased
125,973
-8.9%
$739,0000.0%$5.60
0
2020-Q4
Decreased
138,287
-1.9%
$650,0000.0%$5.02
0
2020-Q3
New
140,960
-
$485,0000.0%$3.49
33

Other major holders of SMMT: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used